Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (7,634,013)	$ (4,826,384)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	8,413	6,236
Accrued stock compensation to employees	271,308	4,810
Accrued stock compensation to non-employees		9,250
Issuance of stock based compensation	50,300
Increase or decrease in:
Accounts receivable	(111,414)	(17,804)
Inventory	(31,021)	26,021
Prepaid clinical expenses	(1,263,914)	20,485
Prepaid insurance and services	(45,717)	65,918
Other	47	412
Accounts payable and accrued expenses	(610,774)	840,600
Total adjustments	(1,732,772)	955,928
NET CASH USED IN OPERATING ACTIVITIES	(9,366,785)	(3,870,456)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of furniture and equipment	(22,500)	(53,127)
Proceeds from mortgage note receivable	20,169	19,332
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	(2,331)	(33,795)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from PPP loan		158,524
Net proceeds from sale of common stock and warrants, and exercise of warrants	7,986,101	1,970,363
NET CASH PROVIDED BY FINANCING ACTIVITIES	7,986,101	2,128,887
NET DECREASE IN CASH AND CASH EQUIVALENTS	(1,383,015)	(1,775,364)
CASH AND CASH EQUIVALENTS, beginning of period	12,846,113	2,783,719
CASH AND CASH EQUIVALENTS, end of period	11,463,098	1,008,355
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest	0	0
Cash paid for income taxes	$ 0	$ 0